(Q38444117)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25915811%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

review article

1 reference

title

Human herpesvirus-6 encephalitis after allogeneic hematopoietic cell transplantation: what we do and do not know (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25915811%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25915811%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

author name string

T Fukuda

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25915811%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

T Teshima

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25915811%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

language of work or name

English

0 references

publication date

27 April 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25915811%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

6 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25915811%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

volume

50

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25915811%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25915811%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

page(s)

1030-1036

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25915811%20AND%20SRC:MED&resulttype=core&format=json

Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation

6 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Impact of human herpesvirus-6 after haematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Human herpesvirus 6 DNA in plasma after allogeneic stem cell transplantation: incidence and clinical significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Risk factors for developing human herpesvirus 6 (HHV-6) reactivation after allogeneic hematopoietic stem cell transplantation and its association with central nervous system disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Human herpesvirus 6 (HHV-6) reactivation and HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: a multicenter, prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Plasma HHV-6 viral load-guided preemptive therapy against HHV-6 encephalopathy after allogeneic stem cell transplantation: a prospective evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Correlations of HHV-6 viral load and plasma IL-6 concentration with HHV-6 encephalitis in allogeneic stem cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Brief report: fatal encephalitis due to variant B human herpesvirus-6 infection in a bone marrow-transplant recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Ratification vote on taxonomic proposals to the International Committee on Taxonomy of Viruses (2012)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

A population-based study of primary human herpesvirus 6 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Quantitative detection and differentiation of human herpesvirus 6 subtypes in bone marrow transplant patients by using a single real-time polymerase chain reaction assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

On the use of causal criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

HHV-6 reactivation and its effect on delirium and cognitive functioning in hematopoietic cell transplantation recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Human herpesvirus 6-related pure red cell aplasia, secondary graft failure, and clinical severe immune suppression after allogeneic hematopoietic cell transplantation successfully treated with foscarnet

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Human herpesvirus 6 reactivation before engraftment is strongly predictive of graft failure after double umbilical cord blood allogeneic stem cell transplantation in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

A case of pneumonitis and encephalitis associated with human herpesvirus 6 (HHV-6) infection after bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

HHV-6 reactivation and associated sequelae after hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Early human herpesvirus type 6 reactivation after allogeneic stem cell transplantation: a large-scale clinical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Chromosomally integrated human herpesvirus 6: questions and answers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

The prevalence of chromosomally integrated human herpesvirus 6 genomes in the blood of UK blood donors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Chromosomal integration of human herpesvirus 6 is the major mode of congenital human herpesvirus 6 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Sequence analysis of transplacentally acquired human herpesvirus 6 DNA is consistent with transmission of a chromosomally integrated reactivated virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Molecular and virological evidence of viral activation from chromosomally integrated human herpesvirus 6A in a patient with X-linked severe combined immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Prevalence of chromosomally integrated human herpesvirus 6 in patients with human herpesvirus 6-central nervous system dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Chromosomally integrated human herpesvirus-6 in transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Transmission of integrated human herpesvirus 6 through stem cell transplantation: implications for laboratory diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Human herpesvirus 6 chromosomal integration in immunocompetent patients results in high levels of viral DNA in blood, sera, and hair follicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Human herpesvirus 6 and central nervous system disease in hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Post-transplant acute limbic encephalitis: clinical features and relationship to HHV6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Risk factors for human herpesvirus 6 reactivation and its relationship with syndrome of inappropriate antidiuretic hormone secretion after stem cell transplantation in pediatric patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Severe hyponatremia caused by syndrome of inappropriate secretion of antidiuretic hormone developed as initial manifestation of human herpesvirus-6-associated acute limbic encephalitis after unrelated bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Cord-blood hematopoietic stem cell transplant confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Symptomatic generalized epilepsy after HHV6 posttransplant acute limbic encephalitis in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

HHV-6 encephalitis in pediatric unrelated umbilical cord transplantation: a role for ganciclovir prophylaxis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Human herpes 6 virus encephalitis complicating allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Myelitis associated with human herpes virus 6 (HHV-6) after allogeneic cord blood transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

High incidence of human herpes virus 6-associated encephalitis/myelitis following a second unrelated cord blood transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Human herpes virus 6-associated myelitis following allogeneic bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Causality in acute encephalitis: defining aetiologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Management of CMV, HHV-6, HHV-7 and Kaposi-sarcoma herpesvirus (HHV-8) infections in patients with hematological malignancies and after SCT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Human herpesvirus 6 meningoencephalitis in allogeneic hematopoietic stem cell transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Human herpesvirus 6 can be detected in cerebrospinal fluid without associated symptoms after allogeneic hematopoietic cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Frequent human herpesvirus-6 viremia but low incidence of encephalitis in double-unit cord blood recipients transplanted without antithymocyte globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Human herpesvirus 6 infection after hematopoietic cell transplantation: is routine surveillance necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Human herpesvirus 6 infection after allogeneic stem cell transplantation: incidence, outcome, and factors associated with HHV-6 reactivation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Human herpesvirus-6 encephalitis following allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Long-term outcome of human herpesvirus-6 encephalitis after allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

HHV-6 encephalitis in umbilical cord blood transplantation: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Activation of human herpesvirus replication by apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

CD134 is a cellular receptor specific for human herpesvirus-6B entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Human herpesvirus 6 encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Variant-specific tropism of human herpesvirus 6 in human astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Differential tropism of human herpesvirus 6 (HHV-6) variants and induction of latency by HHV-6A in oligodendrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Differentiated human neural stem cells: a new ex vivo model to study HHV-6 infection of the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Detection of active human herpesvirus-6 infection in the brain: correlation with polymerase chain reaction detection in cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Human herpesvirus 6 (HHV-6) induces dysregulation of glutamate uptake and transporter expression in astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Inhibition of human herpesvirus 6 replication by 9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine (2HM-HBG) and other antiviral compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Antiviral agents active against human herpesviruses HHV-6, HHV-7 and HHV-8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Comparison of antiviral compounds against human herpesvirus 6 and 7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Penetration of foscarnet into cerebrospinal fluid of AIDS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Comparative activities of lipid esters of cidofovir and cyclic cidofovir against replication of herpesviruses in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Potent, selective and cell-mediated inhibition of human herpesvirus 6 at an early stage of viral replication by the non-nucleoside compound CMV423.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Synthesis and antiviral activities of methylenecyclopropane analogs with 6-alkoxy and 6-alkylthio substitutions that exhibit broad-spectrum antiviral activity against human herpesviruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Sensitivity of human herpesvirus 6 and other human herpesviruses to the broad-spectrum antiinfective drug artesunate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

First pharmacokinetic and safety study in humans of the novel lipid antiviral conjugate CMX001, a broad-spectrum oral drug active against double-stranded DNA viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

First therapeutic use of Artesunate in treatment of human herpesvirus 6B myocarditis in a child

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Rapid generation of clinical-grade antiviral T cells: selection of suitable T-cell donors and GMP-compliant manufacturing of antiviral T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Immune response to HHV-6 and implications for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Child and adult forms of human herpesvirus 6 encephalitis: looking back, looking forward

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Preemptive therapy of human herpesvirus-6 encephalitis with foscarnet sodium for high-risk patients after hematopoietic SCT

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Dazed and confused by HHV-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.76

Susceptibility of human herpesvirus 6 to antiviral compounds by flow cytometry analysis

21 January 2018

1 reference

12 December 2020

Diagnostic utility of a multiplex herpesvirus PCR assay performed with cerebrospinal fluid from human immunodeficiency virus-infected patients with neurological disorders

1 reference

12 December 2020

Human herpesvirus-6 encephalitis in hematopoietic SCT recipients in Japan: a retrospective multicenter study

1 reference

12 December 2020

Human herpesvirus 6B infection of the large intestine of patients with diarrhea

1 reference

12 December 2020

Human herpesvirus 6 in lung tissue from patients with pneumonitis after bone marrow transplantation

1 reference

12 December 2020

Foscarnet against human herpesvirus (HHV)-6 reactivation after allo-SCT: breakthrough HHV-6 encephalitis following antiviral prophylaxis

1 reference

12 December 2020

The Environment and Disease: Association or Causation?

1 reference

12 December 2020

Human herpesvirus 6 DNA in cerebrospinal fluid specimens from allogeneic bone marrow transplant patients: does it have clinical significance?

1 reference

12 December 2020

The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America

1 reference

12 December 2020

High levels of human herpesvirus 6 DNA in peripheral blood leucocytes are correlated to platelet engraftment and disease in allogeneic stem cell transplant patients

1 reference

12 December 2020

Human herpesvirus-6 encephalitis during hematopoietic stem cell transplantation leads to poor prognosis

1 reference

12 December 2020

HDP-CDV as an alternative for treatment of human herpesvirus-6 infections

1 reference

12 December 2020

Human herpesvirus type 6 and human herpesvirus type 7 infections of the central nervous system.

1 reference

12 December 2020

Human herpesvirus 6: infection and disease following autologous and allogeneic bone marrow transplantation

1 reference

12 December 2020

1 reference

12 December 2020